Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT04094142 · COMPLETED
Trial details
- NCT number
- NCT04094142
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-09
- Primary completion
- 2022-05-15
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.